49 min

We're in a science moment. What will come out of it‪?‬ Aspen Ideas to Go

    • Philosophy

The Covid-19 vaccine was developed at an unusually rapid pace, and now the public's expectations are high for what science can deliver. It's a good thing we're in a science moment. Gobs of data are being produced, researchers are collaborating more, and the public is engaged. But is the pace of discovery keeping up with the science? Alison Snyder, managing editor at Axios, interviews Darío Gil, senior vice president and director of IBM Research at IBM, Serpil Erzurum, chief research and academic officer of Cleveland Clinic, and Nicholas Dirks, president and CEO of the New York Academy of Sciences, about the pace of discovery in an age of streamlined research and development processes and advanced computing.

The Covid-19 vaccine was developed at an unusually rapid pace, and now the public's expectations are high for what science can deliver. It's a good thing we're in a science moment. Gobs of data are being produced, researchers are collaborating more, and the public is engaged. But is the pace of discovery keeping up with the science? Alison Snyder, managing editor at Axios, interviews Darío Gil, senior vice president and director of IBM Research at IBM, Serpil Erzurum, chief research and academic officer of Cleveland Clinic, and Nicholas Dirks, president and CEO of the New York Academy of Sciences, about the pace of discovery in an age of streamlined research and development processes and advanced computing.

49 min

More by The Aspen Institute

Aspen Ideas to Go
The Aspen Institute
The Bridge from The Aspen Institute
The Aspen Institute
LIMINAL
Philip Javellana, Samantha Cherry, Dar Vanderbeck
Behind the Mask
Indu Subaiya, Deb Gordon, Health Innovators Fellowship
Aspen Insight
The Aspen Institute
Business 20/20
The Aspen Institute Business and Society Program